Human rhinoviruses can be classified into major and minor groups on the basis of receptor specificity. Recently, a mouse monoclonal antibody was isolated which selectively blocked the attachment of the major group of human rhinoviruses to cells. Using this monoclonal antibody, the cellular receptor for the major group of human rhinoviruses was isolated. A radioimmunoassay was developed by using the receptor antibody to specifically detect rhinovirus receptor during isolation. Solubilized receptor from detergent-treated HeLa cell membrane extracts eluted from gel filtration columns with an apparent molecular weight of 440 
Cellular receptors play an important role in viral pathogenesis. As a first step in viral infection, viruses attach to specific receptors on the surface of cells. This specific interaction with cells determines, to a large extent, the host-range specificities and tissue tropisms of viruses (5, 7, 9) . Characterization of the host-virus interaction ultimately requires isolation of the cellular receptor and the virion attachment protein. While several virus attachment proteins have been identified (6, 13, 19) , little is known about the nature and identity of most cellular receptors for viruses.
In the past, isolation of receptors from host cells has been hampered by technological problems associated with detecting functional receptors during isolation and in purification of the membrane component(s) (14) . Previous attempts to isolate cellular receptors for viruses have exploited the affinity of the viral ligand for identification and purification of the cellular receptor (9, 28) . This approach has been difficult, presumably because viruses have lower association constants for receptor monomers after solubilization from cellular membranes. However, some virus-receptor interactions are stable in the presence of detergents since a putative receptor protein for the coxsackie B3 virus has been identified by using virus particles (16) .
In this regard, antireceptor monoclonal antibodies may prove more useful as specific, high-affinity reagents for the isolation and characterization of viral receptors. The use of monoclonal antibodies as immunoaffinity probes has been a powerful tool in purifying detergent-solubilized receptors which are present in low quantities on cellular membranes. Monoclonal antibodies have been successfully utilized in the isolation and characterization of various receptor proteins such as the insulin, P-adrenergic, and transferrin receptors (22) . A cellular glycoprotein, which appears to be the 1B-adrenergic receptor, was recently identified as the reovirus receptor by using an anti-idiotypic monoclonal antibody prepared against antibodies to the reovirus 3 hemagglutinin protein (4) . In addition, monoclonal antibodies have been isolated which specifically block the attachment of polio-* Corresponding author.
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virus and coxsackie B virus to cells and which may be helpful in identifying the cellular receptors for these viruses (3, 18) .
The human rhinoviruses (HRVs) are members of the picornavirus family and are the major causative agent of the common cold (8) . Previous studies have shown that HRVs can be divided into major and minor groups on the basis of receptor specificity (1, 4a, 15 Membrane preparation. Cell monolayers were treated with 50 mM EDTA in phosphate-buffered saline (PBS) for 10 to 15 min at 37°C to detach cells. Cells were pooled and then washed three times in PBS. Cells were swollen in 10 mM phosphate buffer and disrupted by Dounce homogenization. Cell debris and nuclei were removed by pelleting at 1,000 x g for 5 min, and membranes were pelleted from the resulting supernatant at 200,000 x g for 1 h at 4°C. The crude membrane pellet was resuspended in PBS to a final concentration of 8 mg of protein per ml and stored at -70°C.
Membrane binding assay. In vitro membrane binding assays have been described previously (4a) . Briefly, HeLa cell membranes (20 ,u) were incubated for 30 min with 10 ,ul of various dilutions of polyclonal serum in PBS before the addition of 10 ,ul (104 cpm) of [35S]methionine-labeled HRV or poliovirus or 10 ,u1 of 125I-labeled receptor antibody. After incubation with virus for 1 h at 25°C or for 30 min with antibody, the membranes were pelleted at 12,000 x g for 2 min, radioactivity in the supematants was counted. Pellets were suspended in 0.2 ml of 1% sodium dodecyl sulfate (SDS) and were also counted to determine percent binding.
Membrane solubilization. Membrane preparations were pelleted 10 min at 35,000 x g and suspended at 6.6 mg/ml in 0.3% sodium deoxycholate prepared fresh in 20 mM Tris hydrochloride (pH 7.4) plus 1 mM phenylmethylsulfonyl fluoride (Sigma Chemical Co., St. Louis, Mo.). After incubation at 4°C for 40 min, the extracts were centrifuged at 100,000 x g for 45 min in a Beckman Ti70.1 rotor at 4°C. Solubilized extracts (supernatants) were stored at 0°C.
Receptor radioimmunoassay (RIA). Nitrocellulose paper was equilibrated with PBS in a Schleicher & Schuell filtration manifold. Solubilized HeLa membrane supernatants were adsorbed to nitrocellulose for 2 to 24 h at 4°C. Unbound protein was removed with PBS, and the nitrocellulose paper was blocked with 20% fetal calf serum in 0.15 M NaCl-0.05 M Tris hydrochloride (pH 7.6)-0.01% sodium azide for 1 to 2 h at room temperature. The nitrocellulose paper was then incubated with 125I-labeled receptor monoclonal antibody in PBS containing 0.02% bovine serum albumin for 2 h at room temperature. The unadsorbed material was removed by washing with PBS containing 0.05% Triton X-100, and the paper was assayed for radioactivity.
Gel ifitration. Solubilized membrane supernatants (0.5 ml)
were chromatographed on a Pharmacia Superose 12 column with a Bio-Rad model 1330 high-pressure liquid chromatography system. The column was run at 1 mllmin with 0.3% sodium deoxycholate in 20 mM Tris hydrochloride (pH 7.4) as a running buffer. Fractions (0.3 ml) were collected, and 80-pul aliquots were tested in the radioimmunoassay. Affinity chromatography. Receptor monoclonal antibody (5 mg) was coupled to 1 ml of Bio-Rad Affi-Gel 10 in 0.1 M NaHCO3 (pH 8.3) according to the Bio-Rad instructions, and the column was equilibrated with 0.3% sodium deoxycholate in 20 mM Tris hydrochloride (pH 7.4)-0.15 M NaCl. Solubilized membrane supernatants were chromatographed through the resin, and unadsorbed protein was washed from the column with 0.5% sodium deoxycholate in 20 mM Tris hydrochloride (pH 7.4). Adsorbed receptor was then eluted with 50 mM diethylamine (pH 11.5), lyophilized, and stored at 40C.
Preparation of polyclonal antiserum. Antiserum was prepared by immunizing New Zealand White rabbits with 10 ,ug of immunoaffinity-purified receptor protein in complete Freund adjuvant administered intradermally. Four weeks later, an additional 10 pug of receptor protein in incomplete VOL. 58, 1986 on July 11, 2017 by guest http://jvi.asm.org/ Downloaded from (4a) .
The antibody binding could be reduced 10-fold by preincubation with unlabeled receptor antibody (Fig. 1B) . Substi evidenced by an undetectable amount of receptor protein present in the starting material (lane 2), a 4,000-fold purification of the putative receptor protein was achieved after a single pass through the immunoaffinity column. The 90-kDa protein was present in all the receptor peaks (discussed above). While a protein of similar molecular weight could be isolated from chimpanzee liver cells, no equivalent proteins were isolated from solubilized extracts of mouse L or HEp-2 cells by immunoaffinity chromatography (data not shown).
Polyclonal antisera to purified HRV receptor. To prove that the isolated 90-kDa protein was the receptor protein for the major group of HRVs, rabbits were immunized with purified 90-kDa receptor protein to generate polyclonal antiserum. The ability of the polyclonal antiserum to selectively inhibit HRV virus attachment to susceptible cells was tested by both membrane binding and cell protection assays. Results showed that the addition of increasing amounts of receptor antiserum corresponded to an increased inhibition of 35S-labeled HRV-15 binding to HeLa membranes (Fig. 4) . No inhibition of virus binding was observed with dilutions of control antiserum. Membrane binding assays (Table 1) involving HRV-2 (minor group) and poliovirus type 1 indicated that the polyclonal antiserum showed the same receptor specificity as the receptor monoclonal antibody in that it could not inhibit the binding of other picornaviruses. In addition, the polyclonal antiserum was capable of blocking the attachment of 125I-labeled receptor monoclonal antibody to HeLa cell membranes (Table 1) . Similar to the receptor antibody, the polyclonal antiserum was able to selectively protect HeLa cell monolayers from infection by HRV-14 and HRV-15 (major HRV group) and coxsackie A13 virus but not HRV-2 (minor HRV group) or poliovirus ( Table 1) . These results confirm that the 90-kDa protein is a receptor protein utilized by the major group of HRVs during attachment.
Cellular function of HRV receptor. To assess the importance of the HRV receptor protein to normal cell growth and division, sparse HeLa cell monolayers were treated with excess receptor antibody for 6 days, and cell counts were done on days 3 and 6 as described in Materials and Methods. The results (Fig. 5 (4a) . The HRV receptor was purified by using biochemical techniques typically applied to the isolation of other membrane receptors and proteins.
Critical for the successful isolation of the receptor protein was the development of a convenient and highly specific RIA to detect the receptor during purification. The RIA measured the binding of radiolabeled receptor antibody to solubilized receptor immobilized on nitrocellulose. A similar assay, in which solubilized membranes were adsorbed to microtiter plates, was used by Crowell and co-workers to characterize the coxsackie B virus receptor (10) . However, it was our experience that the use of nitrocellulose provided a more efficient assay for binding receptor antibody. When HeLa cell membranes were solubilized with deoxycholate, the HRV receptor remained in the supernatants after centrifugation at 100,000 x g and eluted as a peak of ca. 440 kDa from gel filtration columns. The peak fractions contained a variety of proteins in addition to the 90-kDa receptor protein when analyzed on SDS-gels. The size of the receptor complex varied with detergent concentrations, suggesting that the receptor migrated as an aggregate or mini-micelle on the column. A single protein with a molecular weight of 90,000 was isolated after purification of membrane extracts on immunoaffinity columns containing cross-linked receptor antibody. A nearly identical receptor protein could also be isolated from chimpanzee liver cells, which are capable of binding both the major group of HRVs and the receptor antibody (data not shown). However, no receptor protein could be isolated by immunoaffinity chromatography of extracts of mouse L cells or HEp-2 cells, which lack the ability to bind major group HRVs (data not shown).
Further proof that the 90-kDa receptor protein was involved in specific HRV attachment was obtained by using polyclonal rabbit antiserum prepared against the isolated receptor protein. The polyclonal antiserum demonstrated the precise specificity of the receptor monoclonal antibody ( Fig. 4; Table 1 ). Both the polyclonal and monoclonal antibodies inhibited the attachment of the major group of HRVs and coxsackie A virus, but not other viruses, to cells. In addition, the polyclonal antiserum could effectively compete with attachment of 1251I-labeled receptor antibody ( Table   1 ).
The location of the virus attachment site on the HRV capsid is of considerable importance, since it represents a highly conserved region among the numerous antigenically distinct HRV serotypes. Recently, the atomic structure of HRV-14, a HRV major group virus, was determined to within 0.3-nm resolution by X-ray crystallography and nucleic acid sequencing (2, 18a, 21) . Using this structural information and the sequence of naturally occurring variants resistant to numerous neutralizing antibodies, the precise location of each of the four neutralizing domains of HRV-14 was mapped to distinct areas in VP1, VP2, and VP3 that face outward toward the viral exterior (19a, 20 The normal cellular function of the HRV receptor protein remains unknown. Previous cell culture studies have indicated that the HRV receptor is ubiquitous in the human body (4a) . It is, therefore, logical to assume that this receptor plays some role in cell growth or maintenance. However, attachment of the receptor antibody does not inhibit cell growth and division in cell culture (Fig. 5) . This result suggests either that this human receptor is not functional in cell culture or that attachment of the receptor antibody does not interfere with its function. This latter possibility would be more likely if the receptor function involved channeling small molecules rather than attachment of a ligand.
Further characterization and sequencing of the receptor protein will inevitably aid in determining its normal cellular function and understanding its interaction with HRVs.
